Edition:
United Kingdom

Biomarin Pharmaceutical Inc (BMRN.OQ)

BMRN.OQ on NASDAQ Stock Exchange Global Select Market

97.84USD
21 Sep 2018
Change (% chg)

$-2.56 (-2.55%)
Prev Close
$100.40
Open
$100.30
Day's High
$100.81
Day's Low
$96.80
Volume
833,728
Avg. Vol
432,897
52-wk High
$106.19
52-wk Low
$75.84

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Jean-Jacques Bienaime

64 2015 Chairman of the Board, Chief Executive Officer

Daniel Spiegelman

59 2012 Chief Financial Officer, Executive Vice President

Henry Fuchs

60 2016 President - Worldwide Research & Development

G. Eric Davis

47 2016 Executive Vice President, General Counsel, Secretary

Jeff Ajer

55 2013 Executive Vice President, Chief Commercial Officer